COVID-19 Impact on Global Biopharmaceutical Third Party Logistics Market Size, Status and Forecast 2020-2026

July 2020 | 131 pages | ID: CB0B71AE589FEN
QYResearch

Abstracts

This report focuses on the global Biopharmaceutical Third Party Logistics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Biopharmaceutical Third Party Logistics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• DHL
• Kuehne + Nagel
• DB Schenker Logistics
• Nippon Express
• C.H. Robinson Worldwide
• UPS Supply Chain Solutions
• DSV
• Sinotrans
• CEVA Logistics
• Expeditors International of Washington
• Dachser
• Panalpina
• GEODIS
• Toll Holdings
• J.B. Hunt (JBI, DCS & ICS)
• Hitachi Transport System
• XPO Logistics
• GEFCO
• Yusen Logistics
• Agility

Market segment by Type, the product can be split into

• Transportation
• Warehousing
• Value-added Services
• Other

Market segment by Application, split into

• Biopharmaceutical Manufacturers
• Biopharmaceutical Distributors
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Biopharmaceutical Third Party Logistics status, future forecast, growth opportunity, key market and key players.
• To present the Biopharmaceutical Third Party Logistics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Biopharmaceutical Third Party Logistics are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Biopharmaceutical Third Party Logistics Revenue
1.4 Market Analysis by Type
  1.4.1 Global Biopharmaceutical Third Party Logistics Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Transportation
  1.4.3 Warehousing
  1.4.4 Value-added Services
  1.4.5 Other
1.5 Market by Application
  1.5.1 Global Biopharmaceutical Third Party Logistics Market Share by Application: 2020 VS 2026
  1.5.2 Biopharmaceutical Manufacturers
  1.5.3 Biopharmaceutical Distributors
  1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Biopharmaceutical Third Party Logistics Industry Impact
  1.6.1 How the Covid-19 is Affecting the Biopharmaceutical Third Party Logistics Industry
    1.6.1.1 Biopharmaceutical Third Party Logistics Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Biopharmaceutical Third Party Logistics Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Biopharmaceutical Third Party Logistics Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Biopharmaceutical Third Party Logistics Market Perspective (2015-2026)
2.2 Biopharmaceutical Third Party Logistics Growth Trends by Regions
  2.2.1 Biopharmaceutical Third Party Logistics Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Biopharmaceutical Third Party Logistics Historic Market Share by Regions (2015-2020)
  2.2.3 Biopharmaceutical Third Party Logistics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Biopharmaceutical Third Party Logistics Market Growth Strategy
  2.3.6 Primary Interviews with Key Biopharmaceutical Third Party Logistics Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Biopharmaceutical Third Party Logistics Players by Market Size
  3.1.1 Global Top Biopharmaceutical Third Party Logistics Players by Revenue (2015-2020)
  3.1.2 Global Biopharmaceutical Third Party Logistics Revenue Market Share by Players (2015-2020)
  3.1.3 Global Biopharmaceutical Third Party Logistics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Biopharmaceutical Third Party Logistics Market Concentration Ratio
  3.2.1 Global Biopharmaceutical Third Party Logistics Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Biopharmaceutical Third Party Logistics Revenue in 2019
3.3 Biopharmaceutical Third Party Logistics Key Players Head office and Area Served
3.4 Key Players Biopharmaceutical Third Party Logistics Product Solution and Service
3.5 Date of Enter into Biopharmaceutical Third Party Logistics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Biopharmaceutical Third Party Logistics Historic Market Size by Type (2015-2020)
4.2 Global Biopharmaceutical Third Party Logistics Forecasted Market Size by Type (2021-2026)

5 BIOPHARMACEUTICAL THIRD PARTY LOGISTICS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Biopharmaceutical Third Party Logistics Market Size by Application (2015-2020)
5.2 Global Biopharmaceutical Third Party Logistics Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Biopharmaceutical Third Party Logistics Market Size (2015-2020)
6.2 Biopharmaceutical Third Party Logistics Key Players in North America (2019-2020)
6.3 North America Biopharmaceutical Third Party Logistics Market Size by Type (2015-2020)
6.4 North America Biopharmaceutical Third Party Logistics Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Biopharmaceutical Third Party Logistics Market Size (2015-2020)
7.2 Biopharmaceutical Third Party Logistics Key Players in Europe (2019-2020)
7.3 Europe Biopharmaceutical Third Party Logistics Market Size by Type (2015-2020)
7.4 Europe Biopharmaceutical Third Party Logistics Market Size by Application (2015-2020)

8 CHINA

8.1 China Biopharmaceutical Third Party Logistics Market Size (2015-2020)
8.2 Biopharmaceutical Third Party Logistics Key Players in China (2019-2020)
8.3 China Biopharmaceutical Third Party Logistics Market Size by Type (2015-2020)
8.4 China Biopharmaceutical Third Party Logistics Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Biopharmaceutical Third Party Logistics Market Size (2015-2020)
9.2 Biopharmaceutical Third Party Logistics Key Players in Japan (2019-2020)
9.3 Japan Biopharmaceutical Third Party Logistics Market Size by Type (2015-2020)
9.4 Japan Biopharmaceutical Third Party Logistics Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Biopharmaceutical Third Party Logistics Market Size (2015-2020)
10.2 Biopharmaceutical Third Party Logistics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Biopharmaceutical Third Party Logistics Market Size by Type (2015-2020)
10.4 Southeast Asia Biopharmaceutical Third Party Logistics Market Size by Application (2015-2020)

11 INDIA

11.1 India Biopharmaceutical Third Party Logistics Market Size (2015-2020)
11.2 Biopharmaceutical Third Party Logistics Key Players in India (2019-2020)
11.3 India Biopharmaceutical Third Party Logistics Market Size by Type (2015-2020)
11.4 India Biopharmaceutical Third Party Logistics Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Biopharmaceutical Third Party Logistics Market Size (2015-2020)
12.2 Biopharmaceutical Third Party Logistics Key Players in Central & South America (2019-2020)
12.3 Central & South America Biopharmaceutical Third Party Logistics Market Size by Type (2015-2020)
12.4 Central & South America Biopharmaceutical Third Party Logistics Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 DHL
  13.1.1 DHL Company Details
  13.1.2 DHL Business Overview and Its Total Revenue
  13.1.3 DHL Biopharmaceutical Third Party Logistics Introduction
  13.1.4 DHL Revenue in Biopharmaceutical Third Party Logistics Business (2015-2020))
  13.1.5 DHL Recent Development
13.2 Kuehne + Nagel
  13.2.1 Kuehne + Nagel Company Details
  13.2.2 Kuehne + Nagel Business Overview and Its Total Revenue
  13.2.3 Kuehne + Nagel Biopharmaceutical Third Party Logistics Introduction
  13.2.4 Kuehne + Nagel Revenue in Biopharmaceutical Third Party Logistics Business (2015-2020)
  13.2.5 Kuehne + Nagel Recent Development
13.3 DB Schenker Logistics
  13.3.1 DB Schenker Logistics Company Details
  13.3.2 DB Schenker Logistics Business Overview and Its Total Revenue
  13.3.3 DB Schenker Logistics Biopharmaceutical Third Party Logistics Introduction
  13.3.4 DB Schenker Logistics Revenue in Biopharmaceutical Third Party Logistics Business (2015-2020)
  13.3.5 DB Schenker Logistics Recent Development
13.4 Nippon Express
  13.4.1 Nippon Express Company Details
  13.4.2 Nippon Express Business Overview and Its Total Revenue
  13.4.3 Nippon Express Biopharmaceutical Third Party Logistics Introduction
  13.4.4 Nippon Express Revenue in Biopharmaceutical Third Party Logistics Business (2015-2020)
  13.4.5 Nippon Express Recent Development
13.5 C.H. Robinson Worldwide
  13.5.1 C.H. Robinson Worldwide Company Details
  13.5.2 C.H. Robinson Worldwide Business Overview and Its Total Revenue
  13.5.3 C.H. Robinson Worldwide Biopharmaceutical Third Party Logistics Introduction
  13.5.4 C.H. Robinson Worldwide Revenue in Biopharmaceutical Third Party Logistics Business (2015-2020)
  13.5.5 C.H. Robinson Worldwide Recent Development
13.6 UPS Supply Chain Solutions
  13.6.1 UPS Supply Chain Solutions Company Details
  13.6.2 UPS Supply Chain Solutions Business Overview and Its Total Revenue
  13.6.3 UPS Supply Chain Solutions Biopharmaceutical Third Party Logistics Introduction
  13.6.4 UPS Supply Chain Solutions Revenue in Biopharmaceutical Third Party Logistics Business (2015-2020)
  13.6.5 UPS Supply Chain Solutions Recent Development
13.7 DSV
  13.7.1 DSV Company Details
  13.7.2 DSV Business Overview and Its Total Revenue
  13.7.3 DSV Biopharmaceutical Third Party Logistics Introduction
  13.7.4 DSV Revenue in Biopharmaceutical Third Party Logistics Business (2015-2020)
  13.7.5 DSV Recent Development
13.8 Sinotrans
  13.8.1 Sinotrans Company Details
  13.8.2 Sinotrans Business Overview and Its Total Revenue
  13.8.3 Sinotrans Biopharmaceutical Third Party Logistics Introduction
  13.8.4 Sinotrans Revenue in Biopharmaceutical Third Party Logistics Business (2015-2020)
  13.8.5 Sinotrans Recent Development
13.9 CEVA Logistics
  13.9.1 CEVA Logistics Company Details
  13.9.2 CEVA Logistics Business Overview and Its Total Revenue
  13.9.3 CEVA Logistics Biopharmaceutical Third Party Logistics Introduction
  13.9.4 CEVA Logistics Revenue in Biopharmaceutical Third Party Logistics Business (2015-2020)
  13.9.5 CEVA Logistics Recent Development
13.10 Expeditors International of Washington
  13.10.1 Expeditors International of Washington Company Details
  13.10.2 Expeditors International of Washington Business Overview and Its Total Revenue
  13.10.3 Expeditors International of Washington Biopharmaceutical Third Party Logistics Introduction
  13.10.4 Expeditors International of Washington Revenue in Biopharmaceutical Third Party Logistics Business (2015-2020)
  13.10.5 Expeditors International of Washington Recent Development
13.11 Dachser
  10.11.1 Dachser Company Details
  10.11.2 Dachser Business Overview and Its Total Revenue
  10.11.3 Dachser Biopharmaceutical Third Party Logistics Introduction
  10.11.4 Dachser Revenue in Biopharmaceutical Third Party Logistics Business (2015-2020)
  10.11.5 Dachser Recent Development
13.12 Panalpina
  10.12.1 Panalpina Company Details
  10.12.2 Panalpina Business Overview and Its Total Revenue
  10.12.3 Panalpina Biopharmaceutical Third Party Logistics Introduction
  10.12.4 Panalpina Revenue in Biopharmaceutical Third Party Logistics Business (2015-2020)
  10.12.5 Panalpina Recent Development
13.13 GEODIS
  10.13.1 GEODIS Company Details
  10.13.2 GEODIS Business Overview and Its Total Revenue
  10.13.3 GEODIS Biopharmaceutical Third Party Logistics Introduction
  10.13.4 GEODIS Revenue in Biopharmaceutical Third Party Logistics Business (2015-2020)
  10.13.5 GEODIS Recent Development
13.14 Toll Holdings
  10.14.1 Toll Holdings Company Details
  10.14.2 Toll Holdings Business Overview and Its Total Revenue
  10.14.3 Toll Holdings Biopharmaceutical Third Party Logistics Introduction
  10.14.4 Toll Holdings Revenue in Biopharmaceutical Third Party Logistics Business (2015-2020)
  10.14.5 Toll Holdings Recent Development
13.15 J.B. Hunt (JBI, DCS & ICS)
  10.15.1 J.B. Hunt (JBI, DCS & ICS) Company Details
  10.15.2 J.B. Hunt (JBI, DCS & ICS) Business Overview and Its Total Revenue
  10.15.3 J.B. Hunt (JBI, DCS & ICS) Biopharmaceutical Third Party Logistics Introduction
  10.15.4 J.B. Hunt (JBI, DCS & ICS) Revenue in Biopharmaceutical Third Party Logistics Business (2015-2020)
  10.15.5 J.B. Hunt (JBI, DCS & ICS) Recent Development
13.16 Hitachi Transport System
  10.16.1 Hitachi Transport System Company Details
  10.16.2 Hitachi Transport System Business Overview and Its Total Revenue
  10.16.3 Hitachi Transport System Biopharmaceutical Third Party Logistics Introduction
  10.16.4 Hitachi Transport System Revenue in Biopharmaceutical Third Party Logistics Business (2015-2020)
  10.16.5 Hitachi Transport System Recent Development
13.17 XPO Logistics
  10.17.1 XPO Logistics Company Details
  10.17.2 XPO Logistics Business Overview and Its Total Revenue
  10.17.3 XPO Logistics Biopharmaceutical Third Party Logistics Introduction
  10.17.4 XPO Logistics Revenue in Biopharmaceutical Third Party Logistics Business (2015-2020)
  10.17.5 XPO Logistics Recent Development
13.18 GEFCO
  10.18.1 GEFCO Company Details
  10.18.2 GEFCO Business Overview and Its Total Revenue
  10.18.3 GEFCO Biopharmaceutical Third Party Logistics Introduction
  10.18.4 GEFCO Revenue in Biopharmaceutical Third Party Logistics Business (2015-2020)
  10.18.5 GEFCO Recent Development
13.19 Yusen Logistics
  10.19.1 Yusen Logistics Company Details
  10.19.2 Yusen Logistics Business Overview and Its Total Revenue
  10.19.3 Yusen Logistics Biopharmaceutical Third Party Logistics Introduction
  10.19.4 Yusen Logistics Revenue in Biopharmaceutical Third Party Logistics Business (2015-2020)
  10.19.5 Yusen Logistics Recent Development
13.20 Agility
  10.20.1 Agility Company Details
  10.20.2 Agility Business Overview and Its Total Revenue
  10.20.3 Agility Biopharmaceutical Third Party Logistics Introduction
  10.20.4 Agility Revenue in Biopharmaceutical Third Party Logistics Business (2015-2020)
  10.20.5 Agility Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Biopharmaceutical Third Party Logistics Key Market Segments
Table 2. Key Players Covered: Ranking by Biopharmaceutical Third Party Logistics Revenue
Table 3. Ranking of Global Top Biopharmaceutical Third Party Logistics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Biopharmaceutical Third Party Logistics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Transportation
Table 6. Key Players of Warehousing
Table 7. Key Players of Value-added Services
Table 8. Key Players of Other
Table 9. COVID-19 Impact Global Market: (Four Biopharmaceutical Third Party Logistics Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Biopharmaceutical Third Party Logistics Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Biopharmaceutical Third Party Logistics Players to Combat Covid-19 Impact
Table 14. Global Biopharmaceutical Third Party Logistics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Biopharmaceutical Third Party Logistics Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Biopharmaceutical Third Party Logistics Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Biopharmaceutical Third Party Logistics Market Share by Regions (2015-2020)
Table 18. Global Biopharmaceutical Third Party Logistics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Biopharmaceutical Third Party Logistics Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Biopharmaceutical Third Party Logistics Market Growth Strategy
Table 24. Main Points Interviewed from Key Biopharmaceutical Third Party Logistics Players
Table 25. Global Biopharmaceutical Third Party Logistics Revenue by Players (2015-2020) (Million US$)
Table 26. Global Biopharmaceutical Third Party Logistics Market Share by Players (2015-2020)
Table 27. Global Top Biopharmaceutical Third Party Logistics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biopharmaceutical Third Party Logistics as of 2019)
Table 28. Global Biopharmaceutical Third Party Logistics by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Biopharmaceutical Third Party Logistics Product Solution and Service
Table 31. Date of Enter into Biopharmaceutical Third Party Logistics Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Biopharmaceutical Third Party Logistics Market Size by Type (2015-2020) (Million US$)
Table 34. Global Biopharmaceutical Third Party Logistics Market Size Share by Type (2015-2020)
Table 35. Global Biopharmaceutical Third Party Logistics Revenue Market Share by Type (2021-2026)
Table 36. Global Biopharmaceutical Third Party Logistics Market Size Share by Application (2015-2020)
Table 37. Global Biopharmaceutical Third Party Logistics Market Size by Application (2015-2020) (Million US$)
Table 38. Global Biopharmaceutical Third Party Logistics Market Size Share by Application (2021-2026)
Table 39. North America Key Players Biopharmaceutical Third Party Logistics Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Biopharmaceutical Third Party Logistics Market Share (2019-2020)
Table 41. North America Biopharmaceutical Third Party Logistics Market Size by Type (2015-2020) (Million US$)
Table 42. North America Biopharmaceutical Third Party Logistics Market Share by Type (2015-2020)
Table 43. North America Biopharmaceutical Third Party Logistics Market Size by Application (2015-2020) (Million US$)
Table 44. North America Biopharmaceutical Third Party Logistics Market Share by Application (2015-2020)
Table 45. Europe Key Players Biopharmaceutical Third Party Logistics Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Biopharmaceutical Third Party Logistics Market Share (2019-2020)
Table 47. Europe Biopharmaceutical Third Party Logistics Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Biopharmaceutical Third Party Logistics Market Share by Type (2015-2020)
Table 49. Europe Biopharmaceutical Third Party Logistics Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Biopharmaceutical Third Party Logistics Market Share by Application (2015-2020)
Table 51. China Key Players Biopharmaceutical Third Party Logistics Revenue (2019-2020) (Million US$)
Table 52. China Key Players Biopharmaceutical Third Party Logistics Market Share (2019-2020)
Table 53. China Biopharmaceutical Third Party Logistics Market Size by Type (2015-2020) (Million US$)
Table 54. China Biopharmaceutical Third Party Logistics Market Share by Type (2015-2020)
Table 55. China Biopharmaceutical Third Party Logistics Market Size by Application (2015-2020) (Million US$)
Table 56. China Biopharmaceutical Third Party Logistics Market Share by Application (2015-2020)
Table 57. Japan Key Players Biopharmaceutical Third Party Logistics Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Biopharmaceutical Third Party Logistics Market Share (2019-2020)
Table 59. Japan Biopharmaceutical Third Party Logistics Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Biopharmaceutical Third Party Logistics Market Share by Type (2015-2020)
Table 61. Japan Biopharmaceutical Third Party Logistics Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Biopharmaceutical Third Party Logistics Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Biopharmaceutical Third Party Logistics Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Biopharmaceutical Third Party Logistics Market Share (2019-2020)
Table 65. Southeast Asia Biopharmaceutical Third Party Logistics Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Biopharmaceutical Third Party Logistics Market Share by Type (2015-2020)
Table 67. Southeast Asia Biopharmaceutical Third Party Logistics Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Biopharmaceutical Third Party Logistics Market Share by Application (2015-2020)
Table 69. India Key Players Biopharmaceutical Third Party Logistics Revenue (2019-2020) (Million US$)
Table 70. India Key Players Biopharmaceutical Third Party Logistics Market Share (2019-2020)
Table 71. India Biopharmaceutical Third Party Logistics Market Size by Type (2015-2020) (Million US$)
Table 72. India Biopharmaceutical Third Party Logistics Market Share by Type (2015-2020)
Table 73. India Biopharmaceutical Third Party Logistics Market Size by Application (2015-2020) (Million US$)
Table 74. India Biopharmaceutical Third Party Logistics Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Biopharmaceutical Third Party Logistics Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Biopharmaceutical Third Party Logistics Market Share (2019-2020)
Table 77. Central & South America Biopharmaceutical Third Party Logistics Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Biopharmaceutical Third Party Logistics Market Share by Type (2015-2020)
Table 79. Central & South America Biopharmaceutical Third Party Logistics Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Biopharmaceutical Third Party Logistics Market Share by Application (2015-2020)
Table 81. DHL Company Details
Table 82. DHL Business Overview
Table 83. DHL Product
Table 84. DHL Revenue in Biopharmaceutical Third Party Logistics Business (2015-2020) (Million US$)
Table 85. DHL Recent Development
Table 86. Kuehne + Nagel Company Details
Table 87. Kuehne + Nagel Business Overview
Table 88. Kuehne + Nagel Product
Table 89. Kuehne + Nagel Revenue in Biopharmaceutical Third Party Logistics Business (2015-2020) (Million US$)
Table 90. Kuehne + Nagel Recent Development
Table 91. DB Schenker Logistics Company Details
Table 92. DB Schenker Logistics Business Overview
Table 93. DB Schenker Logistics Product
Table 94. DB Schenker Logistics Revenue in Biopharmaceutical Third Party Logistics Business (2015-2020) (Million US$)
Table 95. DB Schenker Logistics Recent Development
Table 96. Nippon Express Company Details
Table 97. Nippon Express Business Overview
Table 98. Nippon Express Product
Table 99. Nippon Express Revenue in Biopharmaceutical Third Party Logistics Business (2015-2020) (Million US$)
Table 100. Nippon Express Recent Development
Table 101. C.H. Robinson Worldwide Company Details
Table 102. C.H. Robinson Worldwide Business Overview
Table 103. C.H. Robinson Worldwide Product
Table 104. C.H. Robinson Worldwide Revenue in Biopharmaceutical Third Party Logistics Business (2015-2020) (Million US$)
Table 105. C.H. Robinson Worldwide Recent Development
Table 106. UPS Supply Chain Solutions Company Details
Table 107. UPS Supply Chain Solutions Business Overview
Table 108. UPS Supply Chain Solutions Product
Table 109. UPS Supply Chain Solutions Revenue in Biopharmaceutical Third Party Logistics Business (2015-2020) (Million US$)
Table 110. UPS Supply Chain Solutions Recent Development
Table 111. DSV Company Details
Table 112. DSV Business Overview
Table 113. DSV Product
Table 114. DSV Revenue in Biopharmaceutical Third Party Logistics Business (2015-2020) (Million US$)
Table 115. DSV Recent Development
Table 116. Sinotrans Business Overview
Table 117. Sinotrans Product
Table 118. Sinotrans Company Details
Table 119. Sinotrans Revenue in Biopharmaceutical Third Party Logistics Business (2015-2020) (Million US$)
Table 120. Sinotrans Recent Development
Table 121. CEVA Logistics Company Details
Table 122. CEVA Logistics Business Overview
Table 123. CEVA Logistics Product
Table 124. CEVA Logistics Revenue in Biopharmaceutical Third Party Logistics Business (2015-2020) (Million US$)
Table 125. CEVA Logistics Recent Development
Table 126. Expeditors International of Washington Company Details
Table 127. Expeditors International of Washington Business Overview
Table 128. Expeditors International of Washington Product
Table 129. Expeditors International of Washington Revenue in Biopharmaceutical Third Party Logistics Business (2015-2020) (Million US$)
Table 130. Expeditors International of Washington Recent Development
Table 131. Dachser Company Details
Table 132. Dachser Business Overview
Table 133. Dachser Product
Table 134. Dachser Revenue in Biopharmaceutical Third Party Logistics Business (2015-2020) (Million US$)
Table 135. Dachser Recent Development
Table 136. Panalpina Company Details
Table 137. Panalpina Business Overview
Table 138. Panalpina Product
Table 139. Panalpina Revenue in Biopharmaceutical Third Party Logistics Business (2015-2020) (Million US$)
Table 140. Panalpina Recent Development
Table 141. GEODIS Company Details
Table 142. GEODIS Business Overview
Table 143. GEODIS Product
Table 144. GEODIS Revenue in Biopharmaceutical Third Party Logistics Business (2015-2020) (Million US$)
Table 145. GEODIS Recent Development
Table 146. Toll Holdings Company Details
Table 147. Toll Holdings Business Overview
Table 148. Toll Holdings Product
Table 149. Toll Holdings Revenue in Biopharmaceutical Third Party Logistics Business (2015-2020) (Million US$)
Table 150. Toll Holdings Recent Development
Table 151. J.B. Hunt (JBI, DCS & ICS) Company Details
Table 152. J.B. Hunt (JBI, DCS & ICS) Business Overview
Table 153. J.B. Hunt (JBI, DCS & ICS) Product
Table 154. J.B. Hunt (JBI, DCS & ICS) Revenue in Biopharmaceutical Third Party Logistics Business (2015-2020) (Million US$)
Table 155. J.B. Hunt (JBI, DCS & ICS) Recent Development
Table 156. Hitachi Transport System Company Details
Table 157. Hitachi Transport System Business Overview
Table 158. Hitachi Transport System Product
Table 159. Hitachi Transport System Revenue in Biopharmaceutical Third Party Logistics Business (2015-2020) (Million US$)
Table 160. Hitachi Transport System Recent Development
Table 161. XPO Logistics Company Details
Table 162. XPO Logistics Business Overview
Table 163. XPO Logistics Product
Table 164. XPO Logistics Revenue in Biopharmaceutical Third Party Logistics Business (2015-2020) (Million US$)
Table 165. XPO Logistics Recent Development
Table 166. GEFCO Company Details
Table 167. GEFCO Business Overview
Table 168. GEFCO Product
Table 169. GEFCO Revenue in Biopharmaceutical Third Party Logistics Business (2015-2020) (Million US$)
Table 170. GEFCO Recent Development
Table 171. Yusen Logistics Company Details
Table 172. Yusen Logistics Business Overview
Table 173. Yusen Logistics Product
Table 174. Yusen Logistics Revenue in Biopharmaceutical Third Party Logistics Business (2015-2020) (Million US$)
Table 175. Yusen Logistics Recent Development
Table 176. Agility Company Details
Table 177. Agility Business Overview
Table 178. Agility Product
Table 179. Agility Revenue in Biopharmaceutical Third Party Logistics Business (2015-2020) (Million US$)
Table 180. Agility Recent Development
Table 181. Research Programs/Design for This Report
Table 182. Key Data Information from Secondary Sources
Table 183. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Biopharmaceutical Third Party Logistics Market Share by Type: 2020 VS 2026
Figure 2. Transportation Features
Figure 3. Warehousing Features
Figure 4. Value-added Services Features
Figure 5. Other Features
Figure 6. Global Biopharmaceutical Third Party Logistics Market Share by Application: 2020 VS 2026
Figure 7. Biopharmaceutical Manufacturers Case Studies
Figure 8. Biopharmaceutical Distributors Case Studies
Figure 9. Others Case Studies
Figure 10. Biopharmaceutical Third Party Logistics Report Years Considered
Figure 11. Global Biopharmaceutical Third Party Logistics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Biopharmaceutical Third Party Logistics Market Share by Regions: 2020 VS 2026
Figure 13. Global Biopharmaceutical Third Party Logistics Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Biopharmaceutical Third Party Logistics Market Share by Players in 2019
Figure 16. Global Top Biopharmaceutical Third Party Logistics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biopharmaceutical Third Party Logistics as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Biopharmaceutical Third Party Logistics Revenue in 2019
Figure 18. North America Biopharmaceutical Third Party Logistics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Biopharmaceutical Third Party Logistics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Biopharmaceutical Third Party Logistics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Biopharmaceutical Third Party Logistics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Biopharmaceutical Third Party Logistics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Biopharmaceutical Third Party Logistics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Biopharmaceutical Third Party Logistics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. DHL Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. DHL Revenue Growth Rate in Biopharmaceutical Third Party Logistics Business (2015-2020)
Figure 27. Kuehne + Nagel Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Kuehne + Nagel Revenue Growth Rate in Biopharmaceutical Third Party Logistics Business (2015-2020)
Figure 29. DB Schenker Logistics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. DB Schenker Logistics Revenue Growth Rate in Biopharmaceutical Third Party Logistics Business (2015-2020)
Figure 31. Nippon Express Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Nippon Express Revenue Growth Rate in Biopharmaceutical Third Party Logistics Business (2015-2020)
Figure 33. C.H. Robinson Worldwide Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. C.H. Robinson Worldwide Revenue Growth Rate in Biopharmaceutical Third Party Logistics Business (2015-2020)
Figure 35. UPS Supply Chain Solutions Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. UPS Supply Chain Solutions Revenue Growth Rate in Biopharmaceutical Third Party Logistics Business (2015-2020)
Figure 37. DSV Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. DSV Revenue Growth Rate in Biopharmaceutical Third Party Logistics Business (2015-2020)
Figure 39. Sinotrans Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Sinotrans Revenue Growth Rate in Biopharmaceutical Third Party Logistics Business (2015-2020)
Figure 41. CEVA Logistics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. CEVA Logistics Revenue Growth Rate in Biopharmaceutical Third Party Logistics Business (2015-2020)
Figure 43. Expeditors International of Washington Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Expeditors International of Washington Revenue Growth Rate in Biopharmaceutical Third Party Logistics Business (2015-2020)
Figure 45. Dachser Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Dachser Revenue Growth Rate in Biopharmaceutical Third Party Logistics Business (2015-2020)
Figure 47. Panalpina Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Panalpina Revenue Growth Rate in Biopharmaceutical Third Party Logistics Business (2015-2020)
Figure 49. GEODIS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. GEODIS Revenue Growth Rate in Biopharmaceutical Third Party Logistics Business (2015-2020)
Figure 51. Toll Holdings Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Toll Holdings Revenue Growth Rate in Biopharmaceutical Third Party Logistics Business (2015-2020)
Figure 53. J.B. Hunt (JBI, DCS & ICS) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. J.B. Hunt (JBI, DCS & ICS) Revenue Growth Rate in Biopharmaceutical Third Party Logistics Business (2015-2020)
Figure 55. Hitachi Transport System Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Hitachi Transport System Revenue Growth Rate in Biopharmaceutical Third Party Logistics Business (2015-2020)
Figure 57. XPO Logistics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. XPO Logistics Revenue Growth Rate in Biopharmaceutical Third Party Logistics Business (2015-2020)
Figure 59. GEFCO Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. GEFCO Revenue Growth Rate in Biopharmaceutical Third Party Logistics Business (2015-2020)
Figure 61. Yusen Logistics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Yusen Logistics Revenue Growth Rate in Biopharmaceutical Third Party Logistics Business (2015-2020)
Figure 63. Agility Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Agility Revenue Growth Rate in Biopharmaceutical Third Party Logistics Business (2015-2020)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed